OrganizationJan 1996 – Sep 2019

Purdue Pharma

OxyContin maker at the center of the opioid crisis

Purdue Pharma is the U.S. pharmaceutical company owned by the Sackler family that manufactured OxyContin. Internal documents and court filings have made it the most-documented corporate actor in the American opioid crisis.

Purdue Pharma

11 Documented Receipts

Sacklers withdrew $11B offshore while OxyContin fueled 900K deaths

Sackler family directed OxyContin marketing while knowing addiction potential

McKinsey secretly consulted for Purdue Pharma and the FDA simultaneously, then tried to destroy the evidence

The Sackler family and McKinsey conspired to turbocharge OxyContin sales despite knowing it was fueling the opioid crisis

Purdue Pharma knew OxyContin was highly addictive but marketed it as abuse-resistant

Purdue Pharma knew OxyContin was highly addictive but marketed it as safe

Purdue Pharma knew OxyContin addiction potential but marketed as less addictive

Purdue Pharma Knew OxyContin Addiction Risk Despite Marketing as Abuse-Resistant

Richard Sackler predicted a 'blizzard of prescriptions' at OxyContin's launch — then devised a strategy to blame the addicts

Purdue Pharma knowingly misrepresented OxyContin's addiction risk, fueling the opioid epidemic

The Sackler family knew OxyContin was highly addictive and marketed it as safe anyway, fueling the opioid epidemic

Claim missing from this page?

Purdue Pharma

11 Documented Receipts

Sacklers withdrew $11B offshore while OxyContin fueled 900K deaths

Sackler family directed OxyContin marketing while knowing addiction potential

McKinsey secretly consulted for Purdue Pharma and the FDA simultaneously, then tried to destroy the evidence

The Sackler family and McKinsey conspired to turbocharge OxyContin sales despite knowing it was fueling the opioid crisis

Purdue Pharma knew OxyContin was highly addictive but marketed it as abuse-resistant

Purdue Pharma knew OxyContin was highly addictive but marketed it as safe

Purdue Pharma knew OxyContin addiction potential but marketed as less addictive

Purdue Pharma Knew OxyContin Addiction Risk Despite Marketing as Abuse-Resistant

Richard Sackler predicted a 'blizzard of prescriptions' at OxyContin's launch — then devised a strategy to blame the addicts

Purdue Pharma knowingly misrepresented OxyContin's addiction risk, fueling the opioid epidemic

The Sackler family knew OxyContin was highly addictive and marketed it as safe anyway, fueling the opioid epidemic

Claim missing from this page?